IL4 and Alzheimer disease: Furthermore, IL-4 and IL-13 inhibit the skin production of antimicrobial peptides and, thus, predispose AD skin to colonization and infection of Staphylococcus aureus, which further worsens skin inflammation and barrier defects [20].